Evaxion A (EVAX) Common Equity (2019 - 2026)

Evaxion A (EVAX) reported Common Equity of $13.2 million for Q1 2026, up 27.69% on a YoY basis from $10.3 million in Q1 2025, and down 22.49% quarter-over-quarter from $17.0 million in Q4 2025.

Evaxion A (EVAX) Common Equity (2019 - 2026) Analysis & Trends

Evaxion A has reported Common Equity for 8 years, with the latest figure at $13.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Common Equity rose 27.69% year-over-year to $13.2 million; the trailing twelve-month figure through Mar 2026 stood at $13.2 million (up 27.69% YoY), and the FY2025 full-year result was $17.0 million, up 1131.42% from the prior year.
  • Common Equity for Q1 2026 stood at $13.2 million, down from $17.0 million in the prior quarter.
  • The five-year high for Common Equity was $2.6 billion in Q1 2024, with the low at -$4.7 million in Q4 2023.
  • Historically, Common Equity has averaged $171.6 million across 5 years, with a median of $9.3 million in 2022.
  • Annual changes were most pronounced in 2023 — Common Equity sank 156.96% — and 2024, when it soared 31262.16%.
  • Evaxion A's Common Equity stood at $8.3 million in 2022, then plunged by 156.96% to -$4.7 million in 2023, then soared by 65.07% to -$1.7 million in 2024, then surged by 1131.42% to $17.0 million in 2025, then fell by 22.49% to $13.2 million in 2026.
  • The last three Common Equity figures came in at $13.2 million (Q1 2026), $17.0 million (Q4 2025), and $16.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 35.63 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -1.42 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 13.21 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 11.87 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn 31.42 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 13.21 Mn
Dec 31, 2025 17.04 Mn
Sep 30, 2025 16.60 Mn
Jun 30, 2025 6.23 Mn
Mar 31, 2025 10.34 Mn
Dec 31, 2024 -1.65 Mn
Jun 30, 2024 1.25 Mn
Mar 31, 2024 2.60 Bn
Dec 31, 2023 -4.73 Mn
Sep 30, 2023 -2.73 Mn
Jun 30, 2023 2.54 Mn
Mar 31, 2023 8.30 Mn
Dec 31, 2022 8.30 Mn
Sep 30, 2022 13.55 Mn
Jun 30, 2022 26.39 Mn
Mar 31, 2022 26.39 Mn
Dec 31, 2021 32.44 Mn
Sep 30, 2021 16.65 Mn
Jun 30, 2021 21.83 Mn
Mar 31, 2021 27.80 Mn